Nandivada, V. | Search bioRxiv

bioRxiv2023

Monkeybread: A Python toolkit for the analysis of cellular niches in single-cell resolution spatial transcriptomics data

Spatial transcriptomics technologies enable the spatially resolved measurement of gene expression within a tissue specimen. With these technologies, researchers can investigate how cells organize into cellular niches which are defined as distinct regions in the tissue comprising a specific composition of cell types or phenotypes. While general-purpose software tools for the exploratory analysis of spatial transcriptomics data exist, there is a need for tools that specialize in the analysis of cellular organization into niches. This can further enhance the downstream application of these data towards drug target discovery, target validation, and biomarker development. We present Monkeybread: A Python toolkit for analyzing cellular organization and intercellular communication in single-cell resolution spatial transcriptomics data. We applied Monkeybread to a human melanoma sample to demonstrate its utility in identifying cellular niches with diverse immunogenic compositions in the tumor microenvironment. We found that these niches were differentially enriched for immunogenic and tolerogenic macrophage populations that could be correlated to T cell abundance. These findings highlight how Monkeybread can be used for revealing underlying biology of the tumor microenvironment, and in the future, for understanding the influence of these niches on response to available treatments and discovery of novel drug targets.

bioinformatics↗

bioRxiv2020

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

Immune checkpoint therapy has produced remarkable improvements in the outcome for certain cancers. To broaden the clinical impact of checkpoint targeting, we devised a strategy that couples targeting of the cytokine-inducible SH2-containing (CIS) protein, a key negative regulator of interleukin (IL)-15 signaling, with chimeric antigen receptor (CAR) engineering of natural killer (NK) cells. This combined strategy boosted NK cell effector function through enhancing the Akt/mTORC1 axis and c-MYC signaling, resulting in increased aerobic glycolysis. When tested in a lymphoma mouse model, this combined approach improved NK cell anti-tumor activity more than either alteration alone, eradicating lymphoma xenografts without signs of any measurable toxicity. We conclude that combining CIS checkpoint deletion with CAR engineering promotes the metabolic fitness of NK cells in an otherwise suppressive tumor microenvironment. This approach, together with the prolonged survival afforded by CAR modification, represents a promising milestone in the development of the next generation of NK cells for cancer immunotherapy.

immunology↗